跳至主要内容
临床试验/NCT04361305
NCT04361305Unknown3 期

Multicenter Study of the Efficacy and Safety of Dapoxetine Combined With Tadalafil in Men With Premature Ejaculation and Concomitant Erectile Dysfunction

Yan-Ping Huang0 个研究点目标入组 150 人开始时间: 2020年6月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
150
主要终点
The change of Premature Ejaculation Profile (PEP) at week 8

研究概览

简要总结

Premature ejaculation (PE) is a common disease in the andrology clinic. Currently, the effectiveness and outcome differences of drug treatment still need to be studied and demonstrated. Premature ejaculation concurrent with erectile dysfunction (ED) is common in outpatient clinics. The preferred treatment plan for these patients still needs to be further studied and explored, and the difference in the efficacy of different treatment regiments remain to be evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • PE concurrent with ED: the IELT is less than 3 minutes, the PEDT score is ≥11 points, and 5≤IIEF-5≤21 points.
  • 18-60 years old, outpatient or physical examination population, with regular sex partners and regular sex life;
  • Having the data below,and willing to participate in the trial(1)Demographic information: age, gender, nationality, birthplace, etc;(2) Physical examination data: height, weight, abdominal circumference, blood pressure, heart rate, etc ;(3) Medical history data: history of present illness, past medical history, family history, etc;(4) Scale evaluation: Premature Ejaculation Diagnostic Tool (PEDT), Premature Ejaculation Profile (PEP), International Erectile Function Score-5(IIEF-5), Erectile Hardness Grading Score (EHGS), Clinical Global Impression of Change (GICC);

排除标准

  • Age <18 years or> 60 years;
  • There is a history of acute and chronic diseases, major trauma and surgery, etc;
  • A long history of medication;
  • There is a history of unstable myocardial infarction and cerebral infarction;
  • A history of cardiogenic shock, severe heart failure, severe ventricular arrhythmia, etc;
  • There are serious diseases such as malignant tumors, chronic liver and kidney diseases, etc.

研究组 & 干预措施

tadalafil combined with dapoxetine

Experimental

干预措施: Dapoxetine (Drug)

tadalafil combined with dapoxetine

Experimental

干预措施: Tadalafil (Drug)

tadalafil mono group

Active Comparator

干预措施: Tadalafil (Drug)

结局指标

主要结局

The change of Premature Ejaculation Profile (PEP) at week 8

时间窗: Baseline, Week 8

The PEP is a 4-question PRO that asks a respondent about his subjective sense of control over ejaculation, distress related to PE, interpersonal difficulty and satisfaction with sexual intercourse.

The change of International Index of Erectile Function -5(IIEF-5) at week 8

时间窗: Baseline, Week 8

次要结局

  • Incidence of adverse reactions(Baseline, Week 8)
  • The change of Erection Hardness Score (EHS)(Baseline, Week 8)
  • Clinical Global Impression of Change (GICC)(Baseline, Week 8)

研究者

发起方
Yan-Ping Huang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yan-Ping Huang

Department of Urology and Andrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai Jiao Tong University School of Medicine

相似试验